Shire’s New Drugs Defence to AbbVie - Presented by: The Aol. On Network

The fight back is on - the pharmaceutical group Shire is adopting tried and tested tactics to fend off AbbVie. The US firm is offering $46 billion for the British company. Shire says it's not enough and has a promising range of drugs to prove it. It says its current products will generate sales of at least $7 billion by 2020 with $3bln coming from drugs in the pipeline. It's also a serial acquirer - and has benefitted from six deals in the past 13 months.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 14.56 0.23 ▼ 1.56%
AKS $ 4.68 0.31 ▼ 6.21%
FCX $ 14 1.34 ▲ 10.58%
TVIX $ 3.83 0.21 ▲ 5.80%
F $ 13.56 0.53 ▼ 3.76%
AAPL $ 93.74 1.09 ▼ 1.15%
QQQ $ 105.72 0.56 ▼ 0.53%
VALE $ 5.67 0.05 ▲ 0.89%

As of 4/29/2016, 04:15 PM

Latest News Headlines

View All Latest Headlines